Risk stratification based on screening history: The NELSON lung cancer screening study

Uraujh Yousaf-Khan*, Carlijn Van Der Aalst, Pim A. De Jong, Marjolein Heuvelmans, Ernst Scholten, Joan Walter, Kristiaan Nackaerts, Harry Groen, Rozemarijn Vliegenthart, Kevin Ten Haaf, Matthijs Oudkerk, Harry De Koning

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Abstract

Background Debate about the optimal lung cancer screening strategy is ongoing. In this study, previous screening history of the Dutch-Belgian Lung Cancer Screening trial (NELSON) is investigated on if it predicts the screening outcome (test result and lung cancer risk) of the final screening round. Methods 15â €..792 participants were randomised (1:1) of which 7900 randomised into a screening group. CT screening took place at baseline, and after 1, 2 and 2.5â €..years. Initially, three screening outcomes were possible: negative, indeterminate or positive scan result. Probability for screening outcome in the fourth round was calculated for subgroups of participants. Results Based on results of the first three rounds, three subgroups were identified: (1) those with exclusively negative results (n=3856; 73.0%); (2) those with ≥1 indeterminate result, but never a positive result (n=1342; 25.5%); and (3) with ≥1 positive result (n=81; 1.5%). Group 1 had the highest probability for having a negative scan result in round 4 (97.2% vs 94.8% and 90.1%, respectively, p<0.001), and the lowest risk for detecting lung cancer in round 4 (0.6% vs 1.6%, p=0.001). â € Smoked pack-years' and â € screening history' significantly predicted the fourth round test result. The third round results implied that the risk for detecting lung cancer (after an interval of 2.5â €..years) was 0.6% for those with negative results compared with 3.7% of those with indeterminate results. Conclusions Previous CT lung cancer screening results provides an opportunity for further risk stratifications of those who undergo lung cancer screening. Trial registration number Results, ISRCTN63545820.

Original languageEnglish
Pages (from-to)819-824
Number of pages6
JournalThorax
Volume72
Issue number9
DOIs
Publication statusPublished - 1 Sept 2017

Keywords

  • Clinical Epidemiology
  • Lung Cancer
  • Smoking cessation
  • Tobacco and the lung

Fingerprint

Dive into the research topics of 'Risk stratification based on screening history: The NELSON lung cancer screening study'. Together they form a unique fingerprint.

Cite this